<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Li S</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> The systems pharmacology approach is a target prediction model for traditional Chinese medicine and has been used increasingly in recent years. However, the accuracy of this model to other prediction models is yet to be established. &lt;b>Objective&lt;/b> &lt;i>:&lt;/i> To compare the systems pharmacology modelwithexperimental gene chip technology by using these models to predict targets of a traditional Chinese medicine formulain the treatment of primary liver cancer. &lt;b>Methods:&lt;/b> Systems pharmacology and gene chip target predictions were performed for the traditional Chinese medicine formula &lt;i>ZhenzhuXiaojiTang&lt;/i> (ZZXJT). A third square alignment was performed with molecular docking. &lt;b>Results:&lt;/b> Identification of systems pharmacology accounted for 17% of targets, whilegene chip-predicted outcomes accounted for 19%.Molecular docking showed that the top ten targets (excludingcommon targets) of the system pharmacology model had better binding free energies than the gene chip model using twocommon targets as a benchmark. For both models, the core drugs predictions were more consistent than the core small molecules predictions. &lt;b>Conclusion:&lt;/b>In this study, the identified targets of systems pharmacology weredissimilar to those identified by gene chip technology; whereas the core drug and small molecule predictions were similar.</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>768862</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8926147</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment.</pubmed_title><pmcid>PMC8926147</pmcid><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Sun Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment.</name><description>&lt;b>Background:&lt;/b> The systems pharmacology approach is a target prediction model for traditional Chinese medicine and has been used increasingly in recent years. However, the accuracy of this model to other prediction models is yet to be established. &lt;b>Objective&lt;/b> &lt;i>:&lt;/i> To compare the systems pharmacology modelwithexperimental gene chip technology by using these models to predict targets of a traditional Chinese medicine formulain the treatment of primary liver cancer. &lt;b>Methods:&lt;/b> Systems pharmacology and gene chip target predictions were performed for the traditional Chinese medicine formula &lt;i>ZhenzhuXiaojiTang&lt;/i> (ZZXJT). A third square alignment was performed with molecular docking. &lt;b>Results:&lt;/b> Identification of systems pharmacology accounted for 17% of targets, whilegene chip-predicted outcomes accounted for 19%.Molecular docking showed that the top ten targets (excludingcommon targets) of the system pharmacology model had better binding free energies than the gene chip model using twocommon targets as a benchmark. For both models, the core drugs predictions were more consistent than the core small molecules predictions. &lt;b>Conclusion:&lt;/b>In this study, the identified targets of systems pharmacology weredissimilar to those identified by gene chip technology; whereas the core drug and small molecule predictions were similar.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2024-11-10T06:09:18.129Z</modification><creation>2024-11-10T06:09:18.129Z</creation></dates><accession>S-EPMC8926147</accession><cross_references><pubmed>35308212</pubmed><doi>10.3389/fphar.2022.768862</doi></cross_references></HashMap>